CAS: 4637-24-5; N,N-Dimethylformamide Dimethyl Acetal

相似化合物

18503-89-4 18871-66-4 1188-33-6

上下游产品

CAS号1196967-42-6 | CAS号68-12-2 N,N-二甲基甲酰胺 | CAS号77-78-1 硫酸二甲酯 | CAS号1192-62-7 2-乙酰基呋喃 | CAS号350-03-8 3-乙酰吡啶 | CAS号154147-42-9 2-butyl-2-imida... | CAS号124-41-4 甲醇钠 | CAS号1071-38-1 (二甲氨基亚甲基)二甲基氯化铵 | CAS号67-66-3 氯仿 | CAS号598-94-7 N,N-二甲基脲 | CAS号112084-93-2 N-(3-cyano-2-py... | CAS号106129-86-6 3-(dimethylamin... | CAS号106157-94-2 1-(dimethylamin... | CAS号106730-70-5 4-(dimethylamin... | CAS号106073-27-2 3-(DIMETHYLAMIN... | CAS号4909-78-8 N,N-二甲基甲酰胺二新戊基乙缩醛 | CAS号439-14-5 地西泮 | CAS号35520-41-3 反式-3-(二甲氨基)丙烯腈

(Methoxymethylidene)Dimethylammonium Methyl Sulfate置于甲醇,Sodium Methylate体系中,化学反应 20.0H,以59%的收率获得产物n,N-二甲基甲酰胺二甲基缩醛
参考文献:4,4-디플루오로-((2-디알킬아미노)메틸렌)-3-옥소부탄산 알킬에스테르의 새로운 제조방법
标题:4,4-디플루오로-((2-디알킬아미노)메틸렌)-3-옥소부탄산 알킬에스테르의 새로운 제조방법
摘要:这项发明涉及一种用于制备杀菌剂(杀菌剂)如异吡唑(Isopyrazam),塞达克赛(Sedaxane),比萨芬(Bixafen)等的中间体的新制备方法,其用以下化学式(I)表示:4,4-二氟-((2-二甲基氨基)甲基)-3-氧代丁酸烷基酯.[化学式(I)] 在上述化学式(I)中,R₁,R₂分别是c₁~c₄的烷基,R是甲基或乙基.该化合物由二烷基甲酰胺二烷基缩醛和二氟酮酯反应制备而成.

专利信息

专利号:US-11891375-B2
优先权日:2021-07-26
标 题 :Method for the synthesis of 2,4-dimethylpyrimidin-5-ol, intermediates, and method for the synthesis of Lemborexant using the intermediates
发明人：AKHATOU ABDESLAM; DOBARRO RODRÃ?GUEZ ALICIA
权利人:MOEHS IBERICA SL
摘要:A method is for the synthesis of 2,4-dimethylpyrimidin-5-ol, which can be used as an intermediate compound in the synthesis of Lemborexant. The method includes reacting a nitrophenyl compound with N,N-dimethylformamide diethyl acetal.

专利号:US-11274081-B2
优先权日:2016-05-30
标 题:Process for the synthesis of ivacaftor
发明人：REDDY DUMBALA SRINIVASA; KULKARNI AMOL ARVIND; NATARAJAN VASUDEVAN; SHARMA MRITYUNJAY KESHAVPRASAD
权利人:COUNCIL SCIENT IND RES
摘要:The present disclosed an improved process for the synthesis of ivacaftor starting from indole acetic acid ester which can be performed in batch as well as continuous flow synthesis. The present invention further disclosed to a continuous process for the synthesis of compound of formula (II) or formula (III) from compound of formula (I) in continuous flow reactor.

专利号:US-2023286918-A1
优先权日:2020-07-02
标 题:Manufacturing process for 3,5-dichloropicolinonitrile for synthesis of vadadustat
发明人：JURKAUSKAS VALDAS; JUNG YOUNG CHUN; KWON TAESOO; KANNAN ARUNACHALAM; GONDI VIJAYA BHASKER
权利人:AKEBIA THERAPEUTICS INC
摘要:Disclosed herein are methods and processes of preparing vadadustat or a pharmaceutically acceptable salts thereof, and intermediates (e.g., a compound of Formula (I), (I-F), (II), or (IV), or a pharmaceutically acceptable salts thereof) useful for the synthesis of vadadustat.

专利号:US-7122693-B2
优先权日:1988-04-11
标题 :Acetaldehyde acetal compounds, their synthesis, and uses thereof
发明人：BELLEAU EXECUTRIX OF ESTATE PI; DIXIT DILIP M; NGUYEN-BA NGHE
权利人:SHIRE BIOCHEM INC
摘要:The acetaldehyde compounds, 2-thiobenzoylacetaldehyde diethylacetal, 2-benzoyloxyacetaldehyde bis(2-methoxyethyl)acetal, 2-hydroxyacetaldehyde bis( 2-methoxyethyl)acetal, 2-thiobenzoylacetaldehyde bis(2-methoxy-ethyl)acetal, and 2-thioacetaldehyde bis(2-methoxyethyl)acetal, are useful as intermediates in the synthesis of substituted 1,3-oxathiolanes and substituted 1,3-dioxolanes.

专利号:US-8334381-B2
优先权日:2006-11-16
标题 :Process for the preparation of intermediates useful in the synthesis of imatinib
发明人：FALCHI ALESSANDRO; GRENDELE ENNIO; MOTTERLE RICCARDO; STIVANELLO MARIANO
权利人:FALCHI ALESSANDRO; GRENDELE ENNIO; MOTTERLE RICCARDO; STIVANELLO MARIANO; ITALIANA SINT SPA
摘要:It is the object of the present invention a process for the preparation of 4-methyl-N3-[4-(3-pyridinyl)-2-pyrimidinyl]-1,3-benzenediamine and analogues thereof, intermediates useful for the synthesis of Imatinib, or 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide.

专利号:US-10040752-B2
优先权日:2015-08-24
标 题 :Synthesis of levomethadone hydrochloride or dextromethadone hydrochloride and methods for use thereof
发明人：MKRTCHYAN GNEL; YAO QINGWEI
权利人:CODY LABORATORIES INC
摘要:Highly efficient methods for synthesis of levomethadone hydrochloride or dextromethadone hydrochloride are provided starting from D-alanine, or L-alanine, respectively, with retention of configuration. Methods for treating a subject are provided comprising administering a composition comprising an effective amount of levomethadone hydrochloride having not more than 10 ppm dextromethadone.